• 1.

    Birkett A, Miller RS, Soisson LA, 2022. Malaria in 2022: The importance of exercising caution when comparing results from malaria vaccines administered on the EPI schedule and on a seasonal schedule. Am J Trop Med Hyg: doi: 10.4269/ajtmh.22-0544a.

  • 2.

    Rosenthal PJ, 2022. Malaria in 2022: Challenges and progress. Am J Trop Med Hyg 106: 1565–1567.

Past two years Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 4251 4251 275
PDF Downloads 164 164 27
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 

 

 

Response to “The Importance of Exercising Caution When Comparing Results from Malaria Vaccines Administered on the EPI Schedule and on a Seasonal Schedule”

Philip J. RosenthalDepartment of Medicine University of California San Francisco, California E-mail: philip.rosenthal@ucsf.edu

Search for other papers by Philip J. Rosenthal in
Current site
Google Scholar
PubMed
Close

Dear Sir,

Comments from Drs. Birkett, Miller, and Soisson1 providing context for interpretation of results of malaria vaccine efficacy trials that were discussed in my recent article,2 are much appreciated. Consideration of published efficacies of the RTS,S and R21 malaria vaccines suggests better efficacy with the R21 vaccine. But, as noted, these data are not truly comparable, and full appreciation of the comparative efficacies of these two vaccines will require additional study.

REFERENCES

  • 1.

    Birkett A, Miller RS, Soisson LA, 2022. Malaria in 2022: The importance of exercising caution when comparing results from malaria vaccines administered on the EPI schedule and on a seasonal schedule. Am J Trop Med Hyg: doi: 10.4269/ajtmh.22-0544a.

    • Crossref
    • Export Citation
  • 2.

    Rosenthal PJ, 2022. Malaria in 2022: Challenges and progress. Am J Trop Med Hyg 106: 1565–1567.

    • Crossref
    • Export Citation
Save